11 Results for "

intestinal monolayers

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "intestinal monolayers" in MCE Product Catalog:

21
21 Cited Publications
Cat. No.: HY-U00434
CAS No.: 890405-51-3
Target:  

mTOR Autophagy Apoptosis

Research Areas:  

Infection Inflammation/Immunology

3BDO is a IFITM3 modulator and mTOR activator with antiviral and autophagy-inhibiting effects. 3BDO exhibits inhibitory activity against porcine coronaviruses. 3BDO increases the protein abundance of IFITM3, inhibits virus-cell membrane fusion, and blocks viral entry. 3BDO inhibits the entry of transmissible gastroenteritis virus, porcine epidemic diarrhea virus, and porcine respiratory coronavirus into host cells. 3BDO can be used for research on porcine coronavirus infection .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-134570
CAS No.: 1211825-25-0
Purity:  99.75%
Target:  

FAK

ZINC40099027 is a selective FAK activator. ZINC40099027 promotes FAK phosphorylation, without activating its paralogs Pyk2 and Src. ZINC40099027 promotes the wound closure of human intestinal epithelial monolayers and the healing of mouse ulcers by activating FAK. ZINC40099027 can be used for diseases related to gastrointestinal mucosal injury research .
loading...
    loading...
Cat. No.: HY-148447
CAS No.: 1402931-85-4
Purity:  99.92%
Research Areas:  

Cancer

eIF4A-IN-3, Silvestrol (HY-13251) analogue, is an eIF4A inhibitor. eIF4A-IN-3 blocks protein translation initiation by interfering with eIF4F complex assembly, preferentially inhibiting translation of mRNAs with long, highly structured 5'-untranslated regions. eIF4A-IN-3 inhibits proliferation of human breast cancer cells. eIF4A-IN-3 has moderate apical to basolateral permeability in intestinal cell monolayers and a low efflux ratio .
loading...
    loading...
Cat. No.: HY-138068
CAS No.: 7360-09-0
Purity:  99.93%
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

L-Tryptophanylglycine is a dipeptide. L-Tryptophanylglycine exerts its function through competitive substrate interaction with intestinal dipeptide transporters .
loading...
    loading...
Cat. No.: HY-142686
CAS No.: 2891696-18-5
Target:  

SGK P-glycoprotein CDK

Research Areas:  

Inflammation/Immunology

SGK1-IN-3 (Compound 3a) is an ATP-competitive SGK1 inhibitor with an IC50 of <1 nM against hSGK1. SGK1-IN-3 blocks the activity of CDK family members. SGK1-IN-3 is a P-glycoprotein substrate. SGK1-IN-3 can be used for research on osteoarthritis .
loading...
    loading...
Cat. No.: HY-19771
CAS No.: 1819986-22-5
Synonyms: GSK294; amyloid P-IN-1
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

GSK3039294 is an orally active pro-drug of Miridesap (HY-101861), a circulating serum amyloid P component depleter. GSK3039294 undergoes hydrolysis to form miridesap via a monoester intermediate. GSK3039294 can be used for the research of systemic amyloidosis .
loading...
    loading...
Cat. No.: HY-N3197
CAS No.: 477953-07-4
Synonyms: (+)-Neostenine
Neostenine is a stenine-type Stemona alkaloid, with antitussive activity. Neostenine is also a substrate of P-glycoprotein with high absorptive permeability in Caco-2 monolayer model. Neostenine also shows oral activity for intestinal application .
loading...
    loading...
Cat. No.: HY-P11740
CAS No.: 157173-35-8
VYPFPGPIHN is a precursor peptide of β-casomorphin (HY-P0179) and also an ACE inhibitor (IC50 = 123 μM). VYPFPGPIHN resists hydrolysis by peptidases associated with intestinal cell monolayers, maintaining structural integrity and ACE inhibitory activity. VYPFPGPIHN is not extensively taken up or transported by differentiated intestinal cell monolayers .
loading...
    loading...
Cat. No.: HY-W344531
CAS No.: 75523-11-4
Target:  

Drug Metabolite

Research Areas:  

Inflammation/Immunology

Indomethacin glucuronide is a glucuronide metabolite of Indomethacin (HY-14397) .
loading...
    loading...
Cat. No.: HY-181487
CAS No.: 2769848-56-6
Target:  

FAK

Research Areas:  

Inflammation/Immunology

FAK activator-1 is a FAK activator and mucosal healing inducer.FAK activator-1 increases FAK phosphorylation at Tyr-397, promoting FAK activation.FAK activator-1 promotes mucosal healing.FAK activator-1 can be used for the research of nsaid-associated gastrointestinal mucosal injury .
loading...
    loading...
Cat. No.: HY-167754
CAS No.: 1609382-32-2
Target:  

GPR84

Research Areas:  

Inflammation/Immunology

Resolvin D5 n-3 DPA is a Docosapentaenoic acid (DPA) derived specialized proresolving lipid mediator (SPM). Resolvin D5 n-3 DPA is a GPR101, GPR12, and GPR84 agonist with EC50s of 4.6 pM, 14 pM, and 1.5 pM, respectively. Resolvin D5 n-3 DPA possesses potent pro-resolution and anti-inflammatory actions. Resolvin D5 n-3 DPA reduces cell adhesion onto TNF-α-activated human endothelial monolayers. Resolvin D5 n-3 DPA displays potent leukocyte-directed activities, upregulating the ability of neutrophils and macrophages to phagocytose bacteria. Resolvin D5 n-3 DPA can be used for the study of intestinal inflammation .
loading...
    loading...
  • 1